POLX Share Price Performance
UK£0.0047
-0.01 (-65.96%)
88.4% undervalued intrinsic discount
UK£0.04
Fair Value
Price UK£0.0047
AnalystConsensusTarget UK£0.04
Fair ValueUK£0.04
Share PriceUK£0.0047
88.4% undervalued intrinsic discount
Polarean Imaging plc Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
POLX Community Narratives
AN
Fair Value UK£0.04 89.5% undervalued intrinsic discount
Pharma Trials And Pediatric FDA Approval Will Open Global Markets
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Polarean Imaging plc Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.008
- Gross Margin
- 45.21%
- Net Profit Margin
- -374.12%
- Debt/Equity Ratio
- 0%
Polarean Imaging plc Competitors
Snowflake Analysis
About POLX
- Founded
- 2016
- Employees
- 26
- CEO
- WebsiteView website
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest coil; Polarean 9820 Xenon hyperpolarizer that is designed to deliver up to 3 litres of hyperpolarized 129Xe per hour; and Polarean 2881 polarization measurement station, which provides a calibrated measurement of the polarization of hyperpolarized gas within the dose delivery inhalation bag. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.K. Market Performance
- 7 Days: -0.8%
- 3 Months: 5.4%
- 1 Year: 13.1%
- Year to Date: 13.6%
Over the last 7 days, the market has remained flat, although notably the Real Estate sector declined by 3.5%. Meanwhile, the market is actually up 13% over the past year. As for the next few years, earnings are expected to grow by 14% per annum. Market details ›